Tectonic Therapeutic, Inc.

TECX Nasdaq SEC CIK 1681087
Follow Tectonic Therapeutic Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$21.3M −12.1% vs same quarter last year
EPS, diluted −$1.08 −5.9% vs same quarter last year
Operating cash flow −$14.9M +16.3% vs same quarter last year
Operating income −$23.5M −7.2% vs same quarter last year
Net income by quarter
−$57.9B
−$15.9M
−$20M
−$19M
−$74.1B
−$25.2M
−$22.3M
−$21.3M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income10 fiscal years
−$80B−$60B−$40B−$20B$0FY17FY19FY21FY23FY25
Show the numbers
YearNet income
FY25−$74.2B
FY24−$58B
FY23−$42.8B
FY22−$105.9M
FY21−$119.1M
FY20−$119.7M
FY19−$73M
FY18−$46.4M
FY17−$18.6M
FY16-
Free cash flowOperating cash flow minus capital expenditure
−$150M−$100M−$50M$0FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$60.3M
FY24−$59.2M
FY23−$41M
FY22−$97.5M
FY21−$100.5M
FY20−$100M
FY19−$69.3M
FY18−$39.5M
FY17−$16.8M
FY16-